Actonel 35mg Tablets (pack)

Manufacturer ACTAVIS Active Ingredient Risedronate Tablets(ris ED roe nate) Pronunciation ris ED roe nate
It is used to treat Paget's disease.It is used to prevent or treat soft, brittle bones (osteoporosis).
đŸˇī¸
Drug Class
Bone Resorption Inhibitor
đŸ§Ŧ
Pharmacologic Class
Bisphosphonate
🤰
Pregnancy Category
Category C
✅
FDA Approved
Dec 1998
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Risedronate is a medication used to strengthen bones and reduce the risk of fractures, especially in people with osteoporosis. It works by slowing down the natural process of bone breakdown in your body.
📋

How to Use This Medicine

Taking Your Medication Correctly

To ensure you get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
Take your medication with plain water only. Avoid taking it with mineral water, milk, or other beverages.
Swallow the medication whole. Do not chew, break, or crush it. Also, do not suck on the medication.
Continue taking your medication as instructed by your doctor or healthcare provider, even if you start feeling well.
Take your medication with a full glass of water.
Take it at least 30 minutes before consuming any food, drinks, or other medications for the day.
After taking your medication, do not lie down for at least 30 minutes and wait until you have eaten your first meal of the day.

Storing and Disposing of Your Medication

To maintain the quality and safety of your medication:

Store it at room temperature in a dry place.
Avoid storing it in a bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so.
If you are unsure about the best way to dispose of your medication, consult your pharmacist. You may also have access to drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose of your medication:

Do not take it later in the same day.
Take the missed dose the next morning as soon as you remember, and then return to your regular schedule.
Do not take two doses on the same day.
* If you are unsure about what to do if you miss a dose, contact your doctor for guidance.
💡

Lifestyle & Tips

  • Take the tablet with a full glass (6-8 ounces) of plain water only (no other liquids).
  • Take at least 30-60 minutes before your first food, drink, or other medication of the day.
  • Remain in an upright position (sitting or standing) for at least 30-60 minutes after taking the tablet and until after your first food of the day.
  • Do not lie down after taking the tablet.
  • Do not chew, crush, or suck the tablet.
  • Do not take with mineral water, coffee, juice, or milk.
  • Ensure adequate intake of calcium and vitamin D through diet or supplements, as recommended by your doctor.
  • Engage in weight-bearing exercise as advised by your healthcare provider.
  • Avoid smoking and excessive alcohol consumption, as these can negatively impact bone health.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 35 mg orally once weekly
Dose Range: 35 - 35 mg

Condition-Specific Dosing:

postmenopausal_osteoporosis: 35 mg orally once weekly
male_osteoporosis: 35 mg orally once weekly
glucocorticoid_induced_osteoporosis: 35 mg orally once weekly
pagets_disease: 30 mg orally once daily for 2 months (different strength)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed (CrCl â‰Ĩ 50 mL/min)
Moderate: No adjustment needed (CrCl 30-49 mL/min)
Severe: Contraindicated (CrCl < 30 mL/min)
Dialysis: Contraindicated; not studied in patients on dialysis

Hepatic Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed; not studied in severe hepatic impairment but not expected to be affected due to minimal metabolism

Pharmacology

đŸ”Ŧ

Mechanism of Action

Risedronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption. It binds to hydroxyapatite crystals in bone and inhibits the activity of osteoclasts, thereby decreasing the rate of bone turnover and increasing bone mineral density. This leads to a reduction in the incidence of vertebral and non-vertebral fractures.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 0.63% (oral)
Tmax: Approximately 1 hour
FoodEffect: Food, beverages (other than plain water), and medications containing polyvalent cations (e.g., calcium, magnesium, iron, aluminum) significantly decrease absorption. Bioavailability is reduced by approximately 55% when taken with food.

Distribution:

Vd: Approximately 6.3 L/kg
ProteinBinding: Approximately 24%
CnssPenetration: Limited

Elimination:

HalfLife: Terminal half-life is very long (due to bone binding, estimated to be weeks to years); plasma elimination half-life is approximately 1.5 hours (initial phase)
Clearance: Renal clearance is approximately 100 mL/min
ExcretionRoute: Renal (primarily unchanged)
Unchanged: Approximately 50% of absorbed dose excreted unchanged in urine within 24 hours
âąī¸

Pharmacodynamics

OnsetOfAction: Bone resorption markers decrease within days to weeks; BMD increases typically within 3-6 months.
PeakEffect: Maximal suppression of bone turnover markers typically seen within 3-6 months.
DurationOfAction: Antiresorptive effects persist for a period after discontinuation, but bone turnover markers begin to rise within months.

Safety & Warnings

âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low calcium levels, including:
+ Muscle cramps or spasms
+ Numbness and tingling
+ Seizures
Signs of high blood pressure, such as:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Black, tarry, or bloody stools
Chest pain
Coughing up blood
Vomiting blood or material that looks like coffee grounds
Heartburn
Difficulty swallowing
Severe pain when swallowing
Sore throat
New or unusual pain in the groin, hip, or thigh area
Changes in eyesight, eye pain, or severe eye irritation
Trouble urinating
Pain while urinating

Jawbone Problems

This medication may increase the risk of jawbone problems, particularly with long-term use or in people with certain medical conditions, such as cancer, dental problems, or blood clotting disorders. Other factors that may increase the risk include ill-fitting dentures, anemia, infection, dental work, chemotherapy, radiation, or taking other medications that may cause jawbone problems. If you have any concerns or questions, discuss them with your doctor. If you experience jaw swelling or pain, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild symptoms. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:

Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Bone, joint, or muscle pain
Feeling dizzy, tired, or weak
Headache
Flu-like symptoms

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Difficulty or pain when swallowing (dysphagia)
  • Pain behind the breastbone (chest pain)
  • New or worsening heartburn
  • Severe bone, joint, or muscle pain
  • New or unusual pain in your thigh, hip, or groin
  • Jaw pain, swelling, or numbness
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
Certain health conditions, including:
+ Esophageal problems
+ Difficulty swallowing
+ Low calcium levels
+ Kidney disease
If you are unable to stand or sit upright for at least 30 minutes
If you are currently taking any of the following medications:
+ Cimetidine
+ Dexlansoprazole
+ Esomeprazole
+ Famotidine
+ Lansoprazole
+ Nizatidine
+ Omeprazole
+ Pantoprazole
+ Rabeprazole
+ Ranitidine
* If you are taking another medication that contains the same active ingredient as this drug

Please note that this is not an exhaustive list of all potential interactions. It is crucial to discuss all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. This will help ensure that it is safe to take this medication with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

This drug can cause severe esophageal problems, such as irritation, swelling, ulcers, and bleeding. Be sure to discuss these potential risks with your doctor.

If you have asthma, you should be aware that medications like this one can worsen asthma symptoms. Consult with your doctor to discuss any concerns.

There is a potential increased risk of fractures, particularly in the legs, associated with this medication. Talk to your doctor about this risk and any measures you can take to minimize it.

As directed by your doctor, have your blood work and bone density checked regularly to monitor any potential effects of this medication.

It is crucial to inform all your healthcare providers and laboratory personnel that you are taking this medication, as it may affect the results of certain lab tests.

To maximize the effectiveness of this drug, it is recommended to use it in conjunction with calcium and vitamin D supplements, as well as engage in weight-bearing exercises, such as walking or physical therapy.

Before starting this medication, schedule a dental exam to ensure your teeth and mouth are healthy. Additionally, practice good oral hygiene and visit your dentist regularly for check-ups.

If you plan to consume alcohol, discuss this with your doctor first. Similarly, if you smoke, consult with your doctor about the potential risks and benefits of continuing to smoke while taking this medication.

A rare but severe skin reaction, known as Stevens-Johnson syndrome or toxic epidermal necrolysis, can occur with this medication. This condition can cause severe health problems, permanent damage, and even death. Seek immediate medical attention if you experience symptoms such as red, swollen, blistered, or peeling skin, with or without fever, red or irritated eyes, or sores in your mouth, throat, nose, or eyes.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You will need to discuss the potential benefits and risks of this medication to both you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Hypocalcemia (low blood calcium, symptoms include muscle cramps, spasms, numbness/tingling)
  • Hypophosphatemia (low blood phosphate)
  • Hypomagnesemia (low blood magnesium)
  • Upper gastrointestinal adverse reactions (e.g., esophageal irritation, heartburn, esophagitis, gastritis, ulcer)

What to Do:

Administer milk or antacids containing calcium to bind risedronate. Do not induce vomiting. Seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222).

Drug Interactions

🔴

Major Interactions

  • Antacids (calcium, magnesium, aluminum-containing): Significantly reduce risedronate absorption.
  • Calcium supplements: Significantly reduce risedronate absorption.
  • Iron supplements: Significantly reduce risedronate absorption.
  • Magnesium supplements: Significantly reduce risedronate absorption.
🟡

Moderate Interactions

  • NSAIDs (Nonsteroidal Anti-inflammatory Drugs): Concurrent use may increase the risk of gastrointestinal irritation/ulcers.
  • H2-receptor antagonists/Proton pump inhibitors: May increase gastric pH, potentially affecting risedronate absorption, though clinical significance is debated.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Calcium

Rationale: To ensure normocalcemia before initiating therapy, as hypocalcemia must be corrected.

Timing: Prior to initiation of therapy

Serum Phosphate

Rationale: To ensure normal levels, as hypophosphatemia must be corrected.

Timing: Prior to initiation of therapy

Serum Magnesium

Rationale: To ensure normal levels, as hypomagnesemia must be corrected.

Timing: Prior to initiation of therapy

Renal Function (CrCl)

Rationale: To assess kidney function, as risedronate is renally eliminated and contraindicated in severe renal impairment.

Timing: Prior to initiation of therapy

Dental Examination

Rationale: To identify and address any pre-existing dental disease before starting therapy, especially in patients with risk factors for ONJ.

Timing: Prior to initiation of therapy (consider for high-risk patients)

📊

Routine Monitoring

Serum Calcium

Frequency: Periodically, especially if symptoms of hypocalcemia occur

Target: 8.5-10.2 mg/dL

Action Threshold: < 8.5 mg/dL (correct with calcium/vitamin D supplementation)

Renal Function (CrCl)

Frequency: Periodically, as clinically indicated

Target: > 30 mL/min

Action Threshold: < 30 mL/min (discontinue risedronate)

Bone Mineral Density (BMD)

Frequency: Every 1-2 years

Target: Improvement or stabilization of T-score

Action Threshold: Significant decline in BMD or new fractures (re-evaluate therapy)

đŸ‘ī¸

Symptom Monitoring

  • Dysphagia
  • Esophagitis
  • Esophageal ulceration
  • Chest pain
  • Heartburn (new or worsening)
  • Difficulty swallowing
  • Severe musculoskeletal pain
  • Jaw pain or swelling
  • Numbness or heavy sensation in the jaw
  • Unusual thigh, hip, or groin pain (potential atypical femoral fracture)

Special Patient Groups

🤰

Pregnancy

Risedronate is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Bisphosphonates are incorporated into the bone matrix and are gradually released over years. The extent of fetal exposure is unknown.

Trimester-Specific Risks:

First Trimester: Potential for fetal exposure due to long half-life in bone; risk unknown.
Second Trimester: Potential for fetal exposure due to long half-life in bone; risk unknown.
Third Trimester: Potential for fetal exposure due to long half-life in bone; risk unknown. May cause hypocalcemia in the mother and/or fetus.
🤱

Lactation

It is not known whether risedronate is excreted in human milk. Due to the potential for serious adverse reactions in nursing infants from bisphosphonates, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Risk unknown, but potential for serious adverse effects (e.g., hypocalcemia) in infant. Generally not recommended.
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Use is not recommended.

👴

Geriatric Use

No overall differences in efficacy or safety were observed between elderly and younger patients. No dosage adjustment is necessary based on age alone, but renal function should be monitored as elderly patients are more likely to have decreased renal function.

Clinical Information

💎

Clinical Pearls

  • Patient adherence to dosing instructions (taking with plain water, remaining upright, avoiding food/other meds) is crucial for efficacy and to minimize esophageal adverse events.
  • Ensure patients have adequate calcium and vitamin D intake, as these are essential for bone health and to prevent hypocalcemia.
  • Consider a 'drug holiday' after 3-5 years of bisphosphonate therapy in low-risk patients to reduce the risk of rare but serious adverse events like ONJ and atypical femoral fractures, after discussion with the patient.
  • Educate patients on symptoms of esophageal irritation (chest pain, dysphagia, worsening heartburn) and atypical femoral fractures (new thigh/groin pain) and to report them immediately.
  • A dental examination should be considered prior to initiating bisphosphonate therapy, especially in patients with risk factors for osteonecrosis of the jaw (e.g., cancer, chemotherapy, corticosteroids, poor oral hygiene).
🔄

Alternative Therapies

  • Other oral bisphosphonates (e.g., Alendronate, Ibandronate)
  • Intravenous bisphosphonates (e.g., Zoledronic acid)
  • Denosumab (Prolia)
  • Teriparatide (Forteo)
  • Abaloparatide (Tymlos)
  • Romosozumab (Evenity)
  • Selective Estrogen Receptor Modulators (SERMs) (e.g., Raloxifene)
  • Calcitonin
💰

Cost & Coverage

Average Cost: $50 - $150 per 4 tablets (35mg weekly supply)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 (brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which is a valuable resource for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, we encourage you to discuss them with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the quantity, and the time it occurred.